Femtech Market Report 2025

The femtech market size has grown rapidly in recent years. It will grow from $41.07 billion in 2024 to $46.7 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing women's health awareness, changing societal attitudes and taboos, demand for personalized women's healthcare, shift in women's health conversations, empowerment and informed decision-making.

The femtech market size is expected to see exponential growth in the next few years. It will grow to $100.04 billion in 2029 at a compound annual growth rate (CAGR) of 21%. The growth in the forecast period can be attributed to evolving demographics and aging population, integration of digital health platforms, rise of remote and telehealth services, focus on fertility and reproductive health, preventive and wellness-oriented solutions. Major trends in the forecast period include AI-powered women's health apps, wearable health devices for women, mental health and wellness apps, digital pelvic floor training, investment in femtech startups.

The growth of digital healthcare is anticipated to drive the expansion of the femtech market. Digital healthcare technologies utilize connectivity, software, and sensors for health-related purposes. This surge in digital health is fueled by the increasing demand for remote care, technological advancements, and the need for more efficient healthcare delivery, particularly in the wake of the COVID-19 pandemic. Femtech aligns with digital healthcare by providing technology-driven solutions such as apps, wearables, and telemedicine, which aim to enhance reproductive health, maternal care, and overall wellness, thereby improving access and personalized care for women. For example, in October 2022, a report from the American Medical Association, a US-based professional organization, indicated that the percentage of physicians using tele-visits or virtual visits reached 80%, while those utilizing remote monitoring devices hit 30% in 2022. Consequently, the rise of digital healthcare is expected to significantly propel the growth of the femtech market.

An increase in healthcare spending is projected to further accelerate the growth of the femtech market. Healthcare spending encompasses the total expenditures made by individuals, governments, and organizations within a specific region or country for healthcare-related goods and services. Rising healthcare expenditures promote investment in research, development, and the adoption of innovative women's health technologies within the femtech sector, improving access to cutting-edge products and services for women's health and well-being. For instance, according to the National Health Expenditures Accounts (NHEA) by KFF, a US-based independent source for health policy research, polling, and journalism, health spending in the USA is expected to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Thus, increasing healthcare expenditures are driving the expansion of the femtech market.

Leading companies in the femtech market are concentrating on creating technologically advanced solutions, such as consumer insights and research platforms, to foster innovation within the women's health sector. A consumer insights and research platform is a digital tool or service that gathers, analyzes, and interprets consumer data to understand preferences, behaviors, and trends, enabling businesses to make informed decisions and effectively tailor their marketing strategies. For example, in June 2024, Unfabled, a UK-based women's health platform, introduced Unfabled Labs, a consumer insights and research platform designed to enhance innovation in the women's health sector. By utilizing data from over 400,000 women and non-binary individuals, the platform aims to address the gender health gap and inform the development of tailored products and services.

Major companies in the femtech market are embracing a strategic partnership approach to deliver essential communication services to individuals, businesses, and governments. Strategic partnerships involve a process where companies utilize each other's strengths and resources to achieve mutual benefits and success. For instance, in September 2022, FemTech Lab, a UK-based expert and investor in women's health and wellness, collaborated with XCHG Spaces, a UK-based office space rental agency, to establish FemTech Hub, the first physical innovation center dedicated solely to women's health. The hub's objective is to connect entrepreneurs, investors, and healthcare professionals to promote innovation in the femtech sector. By focusing on addressing women's health challenges, the hub will support startups through educational webinars, roundtables, and a go-to-market program. Members will benefit from a collaborative workspace, exclusive access to London’s femtech community, and a variety of health and wellness amenities.

In July 2022, FemTec Health, a health and beauty sciences company based in the United States, successfully acquired Ava Women for an undisclosed sum. This strategic acquisition is intended to facilitate the expansion of FemTech Health's product portfolio, particularly in the realm of reproductive health solutions. Ava Women, the Switzerland-based company being acquired, specializes in digital diagnostics and therapeutics focused on women's reproductive health.

Major companies operating in the femtech market include Totohealth Inc., LifeSense Group, Lumenis Ltd., Maven Clinic, Kindbody Fertility & Women's Health, Flo Health Inc., Minvera Health Inc., Natural Cycles, NURX Inc., BioWink GmbH, Elvie Inc., Nuvo Group LLC, Lia Diagnostics Inc., Bloomlife Inc., Kasha Global Inc., Proov, Athena Feminine Technologies, Ava Science Inc., Joylux Inc., MedAnswers, OCON Healthcare LLC, Flyte by Pelvital, Inne Inc., Tia Health, Gennev, iSono Health Inc., OOVA Inc., Sera Prognostics Inc., Cora Health Inc., HeraMED Inc., Sustain Natural, LactApp Women’s Health, Trak Fertility, Willow Pump Company, Yono Labs, Zava.

North America was the largest region in the femtech market in 2024. The regions covered in the femtech market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the femtech market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Femtech refers to technology supporting women's health through software, diagnostics, products, and services designed to meet female biological needs.

The main types of femtech encompass devices, software, services, and others. Devices in femtech represent a broad array of tools and products designed for improving women's health. This category includes wearable devices, treatment devices, and various other products tailored to women's health needs. Software in femtech is employed in female-oriented technological products that focus on women's wellness and healthcare. Services within femtech include medical services utilized in women's healthcare, which can involve therapy services dedicated to wellness and healthcare. Femtech serves various end-users, including direct-to-consumer platforms, hospitals, fertility clinics, surgical centers, and diagnostic centers. The applications of femtech cover a range of women's health areas, including reproductive health, pregnancy and nursing care, pelvic and uterine healthcare, general healthcare and wellness, among others.

The femtech market research report is one of a series of new reports that provides femtech market statistics, including femtech industry global market size, regional shares, competitors with a femtech market share, detailed femtech market segments, market trends and opportunities, and any further data you may need to thrive in the femtech industry. This femtech market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The femtech market includes revenues earned by entities by providing period tracker, fertility tracking and solutions, menstruation products, prenatal and postnatal care products, and reproduction healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.